These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9167676)

  • 1. DNA ploidy and proliferating cell nuclear antigen image analysis of peritoneal and pleural effusions. A possible diagnostic role.
    el-Habashi AH; Freeman SM; el-Morsi B; el-Didi M; Martin A; Marrogi AJ
    Acta Cytol; 1997; 41(3):636-48. PubMed ID: 9167676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
    Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and PCNA coexpression of 81 pleural and peritoneal effusion specimens: an immunohistochemical study.
    El-Habashi AH; Freeman SM; el-Morsi B; Morris GF; Marrogi AJ
    Pathol Res Pract; 1996 Aug; 192(8):834-9. PubMed ID: 8897519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis.
    Decker D; Stratmann H; Springer W; Schwering H; Varnai N; Bollmann R
    Pathol Res Pract; 1998; 194(11):791-5. PubMed ID: 9842638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome analysis in effusions as a diagnostic adjunct to cytology.
    Augustus M; Visveshwara RN; Bhargava MK
    Indian J Cancer; 1989 Jun; 26(2):67-75. PubMed ID: 2592000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of FCM-DNA ploidy pattern, AgNOR counting, hTERT and PCNA expression in differentiating malignant from benign serous effusion].
    Wu LY; Liu BR; Lu J; Ling MD; Chen J; Li P; Jiang Y
    Ai Zheng; 2007 Feb; 26(2):178-82. PubMed ID: 17298749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of effusion cytology.
    Motherby H; Nadjari B; Friegel P; Kohaus J; Ramp U; Böcking A
    Diagn Cytopathol; 1999 Jun; 20(6):350-7. PubMed ID: 10352907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
    Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
    Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
    Gandhi AK; Nayar M; Bihari N; Chandra M
    Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
    Sikora J; Dworacki G; Zeromski J
    Lung; 1996; 174(5):303-13. PubMed ID: 8843056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
    Kundu R; Handa U; Mohan H
    Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of toluidine blue-stained wet films in effusion cytology.
    Erkiliç S; Koçer NE
    Acta Cytol; 2006; 50(4):407-9. PubMed ID: 16901004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of DNA analysis in effusions by image analysis and flow cytometry.
    Banks ER; Jennings CD; Jacobs S; Davey DD
    Diagn Cytopathol; 1994; 10(1):62-6; discussion 66-7. PubMed ID: 8005046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of ploidy, AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions.
    Palaoro LA; Blanco AM; Gamboni M; Rocher AE; Rotenberg RG
    Cytopathology; 2007 Feb; 18(1):33-9. PubMed ID: 17250601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA analysis of pleural effusions.
    Huang MS; Tsai MS; Wang TH; Lin MS; Chong IW; Chen KL; Hwang JJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Dec; 8(12):640-6. PubMed ID: 1296045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.